By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Marinus Pharmaceuticals 

21 Business Park Drive

Branford  Connecticut  06405  U.S.A.
Phone: 203-315-0566 Fax: 203-315-0565



Start Up

Company News
Marinus Pharmaceuticals (MRNS) Receives FDA Orphan Drug Designation For Ganaxolone IV To Treat Status Epilepticus 4/15/2016 9:37:44 AM
Marinus Pharmaceuticals (MRNS) Presents Additional Responder Analysis Data For Ganaxolone In Focal Onset Seizures At The American Epilepsy Society Annual Meeting 12/7/2015 12:03:36 PM
Marinus Pharmaceuticals (MRNS) Bolsters Clinical And Regulatory Expertise 12/3/2015 11:20:14 AM
Marinus Pharmaceuticals (MRNS)'s Ganaxolone To Be Featured In Two Poster Presentations At The 69th Annual Meeting Of American Epilepsy Society 11/19/2015 11:07:29 AM
Marinus Pharmaceuticals (MRNS) Announces Public Offering Of Common Stock 11/6/2015 9:27:47 AM
Marinus Pharmaceuticals (MRNS) Provides Business Update And Reports Third Quarter 2015 Financial Results 10/29/2015 11:34:21 AM
Marinus Pharmaceuticals (MRNS) Announces Key Initial Observations From Study In PCDH19 Female Pediatric Epilepsy 10/26/2015 11:50:40 AM
Marinus Pharmaceuticals (MRNS) Announces Positive End-Of-Phase II Meeting With FDA For Ganaxolone In Focal Onset Seizures 9/9/2015 7:20:03 AM
Marinus Pharmaceuticals (MRNS) Provides Business Update And Reports Second Quarter 2015 Financial Results 8/4/2015 10:29:58 AM
Marinus Pharmaceuticals (MRNS) Release: Published Data Support Scientific Basis For Ganaxolone Use In PCDH19 Female Epilepsy 7/6/2015 6:54:27 AM